Title
Category
Credits
Event date
Cost
Hypertension: Evaluation and Treatment
  • On-Demand
  • 0.90 ABN
  • 0.75 ACPE Pharmacy
$0.00
This presentation was developed in conjunction with the Alabama Cardiovascular Cooperative in efforts to educate healthcare providers on the recognition and management of cardiovascular disease and risk factors for cardiovascular disease. This module will review environmental factors that contribute to hypertension as well as secondary and drug induced causes of hypertension. The impact of nonpharmacologic interventions on systolic blood pressure is discussed and treatment thresholds for antihypertensive drug therapy are reviewed.
Electronic Cigarettes and Vaping
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will provide an overview of the history, regulation and marketing of e-cigs, as well as the potential health and safety risks. It will also include counseling points for providers.
Treatment for Tobacco Use Disorder: A Focus on Medications
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will discuss prevalence, impact and treatment of tobacco use disorder. FDA-Approved medications for smoking cessation will be reviewed, including counseling points and access limitations.
Prescription Stimulant Misuse
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will provide information about prescription stimulant misuse. Current statistics of misuse will be presented. Vulnerable populations and rationale for misuse will be discussed. Signs and symptoms of misuse and abuse will be presented along with how to manage patients presenting with toxic effects of prescription stimulants.
Opioid Use Disorder
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will review National and AL data on OUD and use pattern trends. We will discuss risk factors, behavioral clues, and DSM criteria. Epidemiology and prevalence will be discussed. The changing opioid crisis will be discussed with increased emphasis on illicit synthetic opioid use rather than the prescription opioid use driving the current crisis. We will discuss impact of medical cannabis use on patients prescribed opioids for various conditions. 
Recorded - THE ALABAMA PHARMACY COLLABORATIVE PRACTICE ACT: How to get started
  • On-Demand
  • Collaborative Practice Act
  • 4.00 ACPE Pharmacy
$75.00
This program will provide an overview of the Alabama Pharmacy Collaborative Practice Act (CPA) and offer guidance to pharmacists on how to get started. 
Principles of Pharmacogenomics - A recorded program
  • On-Demand
  • 1.00 ACPE Pharmacy
$25.00
This presentation will provide an introduction to the fundamental principles of pharmacogenomics. 
Smoking Cessation: Part 1
  • On-Demand
  • 0.90 ABN
  • 0.75 ACPE Pharmacy
$0.00
This presentation was developed in conjunction with the Alabama Cardiovascular Cooperative in efforts to educate healthcare providers on topics related to cardiovascular disease prevention. This module will focus on incorporating the 5As (Ask, Advise, Assess, Assist, and Arrange) of smoking cessation into everyday practice. Considerations for both patients who are ready to quit smoking and those that are not ready to quit smoking are discussed.
Smoking Cessation: Part 2
  • On-Demand
  • 0.90 ABN
  • 0.75 ACPE Pharmacy
$0.00
This presentation was developed in conjunction with the Alabama Cardiovascular Cooperative in efforts to educate healthcare providers on topics related to cardiovascular disease prevention. This is part 2 of a two-part CE series. The focus of this presentation is pharmacotherapy for smoking cessation. FDA-approved products are discussed including general considerations, dosing, and patient education.
Recorded Dual Antiplatelet Therapy in Acute Coronary Syndrome Following Percutaneous Coronary Intervention - Dr. Alyssa Osmonson
  • On-Demand
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
$25.00
The use of dual antiplatelet therapy and its duration in acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI) is rapidly evolving. This presentation will focus on reviewing current evidence and recommendations on the use of DAPT in ACS post-PCI, with a focus on duration. 

Pages